Major outcomes after allogeneic HCT according to statin treatment of donor and recipient. Cumulative incidence of chronic extensive GVHD (A), NRM (B), recurrent malignancy/progression (C), and Kaplan-Meier estimate for overall survival (D). (R) and (D) indicate patient and donor, respectively. (+) and (−) indicate absence or presence, respectively, of statin treatment. P values are derived from log-rank test.